APA (7th ed.) Citation

Korolev, M. A., Ubshaeva, Y. B., Banshchikova, N. Y., Letyagina, E. A., & Mullagaliev, A. A. (2021). The results of investigating the efficacy and safety of non-medical switching from the original rituximab to its biosimilar in rheumatoid arthritis patients (AMBIRA study). IMA PRESS LLC.

Chicago Style (17th ed.) Citation

Korolev, M. A., Yu. B. Ubshaeva, N. Y. Banshchikova, E. A. Letyagina, and A. A. Mullagaliev. The Results of Investigating the Efficacy and Safety of Non-medical Switching from the Original Rituximab to Its Biosimilar in Rheumatoid Arthritis Patients (AMBIRA Study). IMA PRESS LLC, 2021.

MLA (9th ed.) Citation

Korolev, M. A., et al. The Results of Investigating the Efficacy and Safety of Non-medical Switching from the Original Rituximab to Its Biosimilar in Rheumatoid Arthritis Patients (AMBIRA Study). IMA PRESS LLC, 2021.